OMADA HEALTH ($OMDA) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of $0.13 per share, beating estimates of -$0.05 by $0.18. The company also reported revenue of $75,850,000, beating estimates of $71,064,868 by $4,785,132.
Stock price change since market close: +7.06%
You can see Quiver Quantitative's $OMDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
OMADA HEALTH Insider Trading Activity
OMADA HEALTH insiders have traded $OMDA stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:
- SEAN P. DUFFY (Chief Executive Officer) has made 0 purchases and 4 sales selling 280,541 shares for an estimated $4,388,304.
- WEI-LI SHAO (President) sold 5,618 shares for an estimated $90,645
- STEVEN L. COOK (Chief Financial Officer) sold 4,211 shares for an estimated $64,704
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OMADA HEALTH Hedge Fund Activity
We have seen 96 institutional investors add shares of OMADA HEALTH stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- REVELATION CAPITAL MANAGEMENT, LLC added 5,208,034 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,182,776
- MILLENNIUM MANAGEMENT LLC added 2,096,705 shares (+1195.0%) to their portfolio in Q4 2025, for an estimated $33,086,004
- CITADEL ADVISORS LLC added 1,245,277 shares (+5330.1%) to their portfolio in Q4 2025, for an estimated $19,650,471
- A16Z CAPITAL MANAGEMENT, L.L.C. removed 1,153,645 shares (-25.0%) from their portfolio in Q4 2025, for an estimated $18,204,518
- JEFFERIES FINANCIAL GROUP INC. added 1,073,991 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,947,577
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 910,344 shares (-66.0%) from their portfolio in Q4 2025, for an estimated $14,365,228
- MADRYN ASSET MANAGEMENT, LP added 583,800 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,212,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OMADA HEALTH Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Needham issued a "Buy" rating on 11/07/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
To track analyst ratings and price targets for OMADA HEALTH, check out Quiver Quantitative's $OMDA forecast page.
OMADA HEALTH Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 5 analysts offer price targets for $OMDA in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Saket Kalia from Barclays set a target price of $17.0 on 03/03/2026
- Ryan MacDonald from Needham set a target price of $28.0 on 01/22/2026
- Stan Berenshteyn from Wells Fargo set a target price of $17.0 on 01/09/2026
- Sean Dodge from BMO Capital set a target price of $27.0 on 11/13/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
